The Efficacy of Fimasartan for Cardiovascular Events and Metabolic Syndrome (K-MetS Study): Rationale, Design and Participant Characteristics.
about
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension.Clinic and Home Blood Pressure Lowering Effect of an Angiotensin Receptor Blocker, Fimasartan, in Postmenopausal Women with Hypertension.Hyperuricemia and uncontrolled hypertension in treated hypertensive patients: K-MetS StudyFimasartan: A New Angiotensin Receptor Blocker.Gender-specific differences in the incidence of microalbuminuria in metabolic syndrome patients after treatment with fimasartan: The K-MetS study.
P2860
The Efficacy of Fimasartan for Cardiovascular Events and Metabolic Syndrome (K-MetS Study): Rationale, Design and Participant Characteristics.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The Efficacy of Fimasartan for ...... d Participant Characteristics.
@en
type
label
The Efficacy of Fimasartan for ...... d Participant Characteristics.
@en
prefLabel
The Efficacy of Fimasartan for ...... d Participant Characteristics.
@en
P2093
P2860
P356
P1433
P1476
The Efficacy of Fimasartan for ...... d Participant Characteristics.
@en
P2093
Changsoo Kim
Dae Ryong Kang
Jang-Young Kim
Jeong Bae Park
K-MetS study investigators
Min Young Kim
P2860
P304
P356
10.1159/000360965
P577
2014-04-23T00:00:00Z